Orion Antibody Discovery Suite - AbXtract
How to Customize Sequence Liabilities and Assets – Geneious Biologics Support
Observed Antibody Space + miAIRR | Oxford Protein Informatics Group
Accurate detection of liabilities to de-risk antibody development
Utilizing cross-product prior knowledge to rapidly de-risk chemical liabilities in therapeutic antibody candidates | AAPS Open | Full Text
Computational antibody methods schematic. (A) Antibody modelling... | Download Scientific Diagram
Align and Prioritize your Antibody Sequences
Development issues: antibody stability, developability, immunogenicity, and comparability - ScienceDirect
NGS-Enhanced Antibody Discovery - Abterra Biosciences
Frequency of liability motifs in all CDRs. Circles show percentages of... | Download Scientific Diagram
The Therapeutic Antibody Profiler (TAP): Five Computational Developability Guidelines
Development issues: antibody stability, developability, immunogenicity, and comparability - ScienceDirect
Frontiers | Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies | SpringerLink
ENPICOM introduces a powerful liability prediction solution to de-risk antibody development
Developability Predictions for Antibody Engineering and Risk Mitigation | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Identify CDRs and sequence-based liablities
Accurate detection of liabilities to de-risk antibody development
Five computational developability guidelines for therapeutic antibody profiling | PNAS
Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy - ScienceDirect
Antibodies | Free Full-Text | Antibody Aggregation: Insights from Sequence and Structure
Developability Predictions for Antibody Engineering and Risk Mitigation | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Minimizing Method-Induced Deamidation and Isomerization During Antibody Characterization to Ensure Optimal Understanding of Product Quality Attributes
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
Antibodies | Free Full-Text | Antibody Structure and Function: The Basis for Engineering Therapeutics
Specialized Antibody Characterization - Curia Global
